Back to Search
THOMAS LODISE, PHARM.D
Pharmacist
NPI: 1104845429Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP-044975-L(PA)
Research & Publications (20)
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
PMID 19586413·Clin Infect Dis·2009
8-other
Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
PMID 18694905·J Antimicrob Chemother·2008
8-other
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.
PMID 18591266·Antimicrob Agents Chemother·2008
8-other
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.
PMID 18227177·Antimicrob Agents Chemother·2008
2-rct
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
PMID 18384996·Diagn Microbiol Infect Dis·2008
6-review
Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.
PMID 18426898·Antimicrob Agents Chemother·2008
3-trial
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
PMID 17646415·Antimicrob Agents Chemother·2007
8-other
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
PMID 17664322·Antimicrob Agents Chemother·2007
8-other
Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
PMID 17963459·Pharmacotherapy·2007
4-observational
Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
PMID 17709460·Antimicrob Agents Chemother·2007
4-observational
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
PMID 17158943·Antimicrob Agents Chemother·2007
8-other
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
PMID 17205441·Clin Infect Dis·2007
8-other
Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
PMID 17387149·Antimicrob Agents Chemother·2007
4-observational
Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.
PMID 17594206·Pharmacotherapy·2007
6-review
Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates.
PMID 17620244·Infect Control Hosp Epidemiol·2007
8-other
Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.
PMID 16945055·Pharmacotherapy·2006
6-review
Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies.
PMID 16423490·Diagn Microbiol Infect Dis·2006
8-other
Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens.
PMID 15878442·Diagn Microbiol Infect Dis·2005
3-trial
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
PMID 15964499·Diagn Microbiol Infect Dis·2005
8-other
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation.
PMID 15561849·Antimicrob Agents Chemother·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 113 HOLLAND AVE
ALBANY, NY 12208 - Phone
- (518) 694-7292
Quick Facts
- NPI
- 1104845429
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile